WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

TRIPLE NEGATIVE BREAST CANCER: A MOLECULAR SKETCH

Pramod Singh Khatri* and Sonam Pandey

ABSTRACT

Triple-negative breast cancer, portrayed by cancers that don't express estrogen receptor (ER), progesterone receptor (PR), or HER-2 gene, represents an essential clinical challenge in light of the fact that these cancer don't react to endocrine treatment or other accessible targeted agents. The metastatic potential in triple-negative breast cancer is like that of other breast cancer subtypes, yet these cancers are connected with a shorter middle time to backslide and demise. One vital objective is thusly the identification of prognostic elements and markers to dependably select high and low risk subsets of patients with triplenegative cancer for distinctive treatment methodologies of subtypes with differential responsiveness to particular agents. However, a solid prognostic marker has been subtle, and markers have been conflictingly valuable. For instance, epidermal growth factor receptor (EGFR) have been investigated, yet there is still an absence of concession to a standard measure or cutoff for EGFR expression levels regarding prognosis. Correspondingly, in light of the fact that triplenegative status is basically utilized as a surrogate for basal-like breast cancer, particular basal markers have been investigated. Chemotherapy remains the backbone of treatment for triplenegative breast cancer, however imperative impediments still should be overcome in the following couple of years if any noteworthy clinical steps are to be made.

Keywords: Chemotherapy, triple-negative breast cancer, HER2, basal-like breast cancer.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More